Massachusetts General Hospital/Beth Israel Deaconess Med. Ctr./Dana Farber Cancer Institute

Boston, Massachusetts

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumors

Studies at this site

• Study of RXDX-105, Potent RET Inhibitor in Patients With Advanced Lung Cancer and Other Solid Tumors — Completed